GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samjin Pharmaceutical Co Ltd (XKRX:005500) » Definitions » Cyclically Adjusted FCF per Share

Samjin Pharmaceutical Co (XKRX:005500) Cyclically Adjusted FCF per Share : ₩0.00 (As of Sep. 2024)


View and export this data going back to 1988. Start your Free Trial

What is Samjin Pharmaceutical Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Samjin Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Sep. 2024 was . Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩0.00 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Samjin Pharmaceutical Co's average Cyclically Adjusted FCF Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -27.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -20.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Samjin Pharmaceutical Co was 24.00% per year. The lowest was -27.50% per year. And the median was -11.50% per year.

As of today (2024-12-14), Samjin Pharmaceutical Co's current stock price is ₩18050.00. Samjin Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2024 was ₩0.00. Samjin Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Samjin Pharmaceutical Co was 48.15. The lowest was 12.69. And the median was 35.65.


Samjin Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Samjin Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samjin Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Samjin Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,382.69 1,227.08 847.85 550.64 467.10

Samjin Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 562.58 467.10 453.06 - -

Competitive Comparison of Samjin Pharmaceutical Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Samjin Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samjin Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Samjin Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Samjin Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Samjin Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Samjin Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=180.408/*
=

Current CPI (Sep. 2024) = .

Samjin Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 67.867 99.098 0.000
201503 183.381 99.720 0.000
201506 186.986 100.050 0.000
201509 253.427 100.110 0.000
201512 188.028 100.220 0.000
201603 1,024.519 100.560 0.000
201606 630.418 100.790 0.000
201609 1,025.093 101.460 0.000
201612 591.944 101.560 0.000
201703 520.332 102.850 0.000
201706 414.480 102.610 0.000
201709 621.796 103.490 0.000
201712 716.265 102.990 0.000
201803 1,050.183 104.100 0.000
201806 600.567 104.130 0.000
201809 865.474 105.650 0.000
201812 -740.245 104.350 0.000
201903 -810.687 104.490 0.000
201906 467.271 104.880 0.000
201909 468.407 105.200 0.000
201912 819.437 105.120 0.000
202003 736.384 105.540 0.000
202006 201.814 104.870 0.000
202009 -440.779 106.200 0.000
202012 -1,044.300 105.765 0.000
202103 -516.390 107.357 0.000
202106 -909.771 107.579 0.000
202109 -673.975 108.759 0.000
202112 -2,015.426 109.676 0.000
202203 -93.109 111.806 0.000
202206 -313.181 114.083 0.000
202209 -680.448 114.831 0.000
202212 -359.858 115.200 0.000
202303 -160.581 116.550 0.000
202306 -288.218 117.140 0.000
202309 -14.266 119.111 0.000
202312 -494.124 118.848 0.000
202403 870.274 118.848 0.000
202406 1,267.030 0.000
202409 180.408 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Samjin Pharmaceutical Co  (XKRX:005500) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Samjin Pharmaceutical Co was 48.15. The lowest was 12.69. And the median was 35.65.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Samjin Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Samjin Pharmaceutical Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Samjin Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
121, Wausan-ro, Mapo-Ku, Seoul, KOR, 121-837
Samjin Pharmaceutical Co Ltd is a part of the healthcare sector in Korea. The company functions as a pharmaceutical product manufacturer addressing severe diseases such as osteoporosis, hepatitis, respiratory and gastrointestinal diseases. Its suite of products includes capsules, syringes, injection medicines, and solvents.

Samjin Pharmaceutical Co Headlines

No Headlines